Moderna Q1 profit triples on robust COVID vaccine sales
By TOM MURPHY COVID-19 vaccine sales helped Moderna triple its net income in a better-than-expected first quarter. The vaccine maker said Wednesday that revenue from its coronavirus preventive shots jumped to $5.92 billion from $1.73 billion in last year’s quarter, when the vaccines were debuting in most markets. More than 217 million doses of Moderna’s…
Read more